<DOC>
	<DOCNO>NCT00276458</DOCNO>
	<brief_summary>The purpose study evaluate compare efficacy safety ezetimibe plus atorvastatin versus atorvastatin hypercholesterolemic patient moderately high risk coronary heart disease adequately control atorvastatin 20 mg .</brief_summary>
	<brief_title>To Evaluate Ezetimibe Plus Atorvastatin Versus Atorvastatin Patients With High Cholesterol Not Controlled Atorvastatin 20 mg ( 0653-079 ) ( COMPLETED )</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Ezetimibe</mesh_term>
	<criteria>Patient LDLC &gt; 100 mg/dL &amp; stable dose atorvastatin 20 mg Pregnant lactate woman intend become pregnant Patient sensitivity intolerance ezetimibe atorvastatin Patient diabetes coronary heart disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>